Arachnoid cysts possess several features that make them ideal targets for primary endoscopic fenestration. First, the target membrane is typically avascular. Second, there are generous amounts of CSF for optimal image transmission. Third, the technique of membrane fenestration is amply familiar to surgeons regularly practicing neuroendoscopy, principally through the experience of performing endoscopic third ventriculostomy. Lastly, there is no traditional approach that is universally agreed upon as being optimal. While the rationale for primary endoscopic fenestration has been collectively accepted for some arachnoid cyst variants, notably the prepontine arachnoid cyst, there justifiably remains considerable disagreement about its role for cysts of the middle temporal fossa. [5] [6] [7] [8] [9] [10] [11] In reading the recent publication by Dr. El-Ghandour, 4 one would conclude that much of the ongoing debate regarding optimal management of middle cranial fossa arachnoid cysts (MCFACs) has come to closure. Of 32 children with "symptomatic" arachnoid cysts treated with a purely endoscopic fenestration, reported rates of improvement were 87.5% for clinical assessment and 71.9% for radiographic dimensions. Furthermore, 100% of patients with preoperative headache or skull deformity showed improvement. These admirable results include a low complication rate that was composed of a clinically silent subdural hygroma in 2 children and a transient third cranial nerve paresis in 1 patient. While these results could redefine our expectations regarding this form of treatment for children with MCFACs, a degree of caution is called for because these findings are appreciably incongruous with recently published clinical results as well as our own personal experience. 3, 5, 9 With regard to operative indications, we support the consensus that treatment should be reserved for symptomatic patients. [2] [3] [4] [5] [6] [7] 9, 10 The operative indications included in the current paper beg some clarification. While there is no argument about offering treatment to children with raised intracranial pressure, the interpretation of this finding is frequently subjective. The definition of "symptomatic" in this current series included cranial deformity (temporal bulging), a frequent finding in infants and young children who are otherwise without symptoms. Further, 72% of children underwent treatment due either to symptoms of headache or signs of macrocrania. These features frequently are not related to elevated intracranial pressure. The rate and trend of head circumference growth (unknown in the current paper) is more meaningful than a single measurement. Similarly, headache alone without supportive evidence can be tenuous as a sole justification for surgery. While papilledema is unambiguous in documenting raised intracranial pressure, the frequency of that finding (37.5%) in this cohort of 32 children is appreciably higher than in most reported series. 5, 9 While the author notes that prophylactic surgery may be offered to avoid the potential of subdural hematoma, there exists limited clinical data to discount this notion. Recent evidence is convincingly clear that the potential for symptomatic progression in an otherwise asymptomatic child is exceedingly rare. 1 In fact, the association of intracranial hemorrhage with arachnoid cysts has been documented after head injury despite long-term postsurgical neuroradiological confirmation of MCFAC size reduction and symptom resolution. 9 In short, the indications for surgical treatment of MCFAC are highly variable and open to interpretation.
The outcome in this series of 32 patients is even more impressive given the described technique. The author used an embolectomy catheter to create a single fenestration in 75% of patients without intraoperative computer-assisted neuronavigation. This "simple" technique of endoscopic fenestration warrants some elaboration and annotation. Within the heading of endoscopic fenestrations, we believe that those involving arachnoid cysts of the middle cranial fossa are actually the most complex and challenging, a sentiment that is echoed in the published literature. 8 The juxtaposition of critical structures to the mesial membranes, the limited space between these neurovascular limits, and the reliance on a single endoscopic instrument all result in a procedure that can be intimidating and frequently lengthier than a traditional approach. In our experience, the target membrane is commonly multilaminated and often requires utilization of a biportal technique that makes use of a second instrument to create an adequate fenestration.
The widespread application of neuronavigation systems has enhanced accuracy and developed in a complementary and parallel fashion with neuroendoscopy. 5, 6 Orientation within large MCFACs can be difficult and we strongly advocate the use of neuronavigation in these neuroendoscopy cases to enhance the precision and safety of the procedure. In addition, current neuronavigation systems allow for preoperative multiplanar workstation planning of endoscope trajectory and the use of frameless and pinless navigation in the pediatric setting. Even in light of the excellent results by Dr. El-Ghandour, we continue to advocate that stereotaxy be employed to translate a fixed linear trajectory into an ideal entry site.
This current series contributes to the growing body of evidence demonstrating the efficacy of neuroendoscopic fenestration in managing symptomatic MCFACs. However we suggest that a productive debate continue regarding the use of purely endoscopic fenestration until similar outstanding results are reproduced by others using a welldefined set of surgical indications and outcome measures. 
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First of all, I would like to thank Drs. Kandasamy and Souweidane for taking the time to highlight important issues pertaining to my paper. As they point out, the indications for surgical treatment of MCFACs are variable and not well established. However, I tried as much as possible to have a well-defined set of surgical indications. All the patients included in the current series have specific cyst-related clinical symptoms. Headache was present in 12 cases, and it was attributed to increased intracranial pressure as evidenced by the presence of papilledema. I also considered macrocrania in children under 2 years of age, if associated with compression of adjacent brain parenchyma and/or temporal bulging, as an indication for surgery because the potential for brain expansion is still present.
2 Although recommended by others, 5 prophylactic surgery in asymptomatic patients has never been performed in the present study.
There is no argument that intraoperative computerassisted neuronavigation provides increased accuracy and safety to any endoscopic procedure, and it plays a crucial role in some cases of arachnoid cysts such as those that have paraxial location, because no anatomical landmarks can be identified to allow for intraoperative orientation. 4 Nevertheless, I believe that its role in the endoscopic treatment of MCFACs is dispensable for 2 reasons. First, identification of the anatomical landmarks and localization of the fenestration target point are usually easily accomplished if the neurosurgeon becomes familiar in dealing with these cases. Second, in some cases, especially those with Type III cysts, there is increased intracystic pressure, which results in significant CSF loss once the cyst is entered by the working sheath, leading to intraoperative brain shift and errors in measurements.
Purely endoscopic fenestration in MCFACs, with some elaboration, is becoming a simple and safe procedure, which results in a high incidence of clinical and radiological improvement with minimal morbidity. Such results are comparable to microsurgical marsupialization. The excellent results achieved in the current study would support the rationale for primary endoscopic fenestration in the treatment of MCFACs. Another recent study using a purely endoscopic fenestration has also reported almost the same results with a low complication rate, 3 which adds to the documentation of the efficacy and safety of the procedure.
Of more concern should be the incidence of reclosure of these fenestrations during long-term follow-up. It has been reported that MCFACs have been associated with high postoperative recurrence rates due to membrane thickness and vascularity. 1 Whether the concomitant use of other visualization tools such as microscopy or neuronavigation with endoscopy has any influence on decreasing the incidence of recurrence over the long-term followup remains to be addressed.
